Drug Profile
Research programme: immunological therapies - Immuno Japan
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Immuno Japan
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in Japan
- 11 Apr 2006 Preclinical trials in Undefined in Japan (unspecified route)